Visual field results from a one-year multi-center randomized double-masked study comparing brimonidine tartrate to timolol maleate in the treatment of ocular hypertension and glaucoma

被引：0

作者：

Choplin, NT

机构：

[1] USN,MED CTR,DEPT OPHTHALMOL,SAN DIEGO,CA 92152

[2] USN,MED CTR,DEPT CLIN INVEST,SAN DIEGO,CA 92152

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：2332 / 2332

页数：1

共 47 条

[21] Double-Masked, Randomized, Multi-Center, Examination of Ocular Surface Disease in Glaucoma Patients on Latanoprost With Benzalkonium Chloride (BAK) versus Travoprost BAK-Free
Katz, G. J.
Springs, C. L.
Craven, E. R.
Montecchi-Palmer, M.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
[22] Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma (vol 34, pg 1438, 2017)
Mizoue, Shiro
Nitta, Koji
Shirakashi, Motohiro
Nitta, Akiyoshi
Yamabayashi, Shigeki
Kimura, Tairo
Ueda, Toshihiko
Takeda, Ryuji
Matsumoto, Shun
Yoshikawa, Keiji
ADVANCES IN THERAPY, 2017, 34 (09) : 2179 - 2179
[23] Switching from latanoprost to fixed-combination latanoprot-timolol: A 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension
Olander, K
Zimmerman, TJ
Downes, N
Schoenfelder, J
CLINICAL THERAPEUTICS, 2004, 26 (10) : 1619 - 1629
[24] Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: A six-month, double-masked, multicenter study
Shedden, A
Laurence, J
Tipping, R
CLINICAL THERAPEUTICS, 2001, 23 (03) : 440 - 450
[25] A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study REPLY
Krupin, Theodore
Liebmann, Jeffrey M.
Ritch, Robert
Greenfield, David S.
Gardiner, Stuart
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (05) : 877 - 878
[26] A randomized double-masked crossover study comparing latanoprost 0.005% (xalatan) with unoprostone 0.12% (rescula) in patients with primary open angle glaucoma and ocular hypertension.
Aung, T
Chew, PTK
Yip, CC
See, J
Chang, YH
Khng, CG
Ng, LH
Hoh, ST
Lee, HM
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S282 - S282
[27] Short-Term Tolerability of Once-Daily Timolol Hemihydrate 0.5%, Timolol Maleate in Sorbate 0.5%, and Generic Timolol Maleate Gel-Forming Solution 0.5% in Glaucoma and/or Ocular Hypertension: A Prospective, Randomized, Double-Masked, Active-Controlled, Three-Period Crossover Pilot Study
Sonty, Sriram
Mundorf, Thomas K.
Stewart, Jeanette A.
Stewart, William C.
CLINICAL THERAPEUTICS, 2009, 31 (10) : 2063 - 2071
[28] A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Pediatric, Adult, and Geriatric Subjects
Ngumah, Quintus
Scassellati-Sforzolini, Baldo
Gomes, Paul J.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[29] One-Year Results of a Phase I/II Randomized, Double-Masked, Placebo-Controlled Study of Processed Amniotic Fluid Drops After PRK
Kirschenbaum, Malka Davina
Hu, Katherine S.
Ip, Colin S.
Lin, Amy
Pierce, Jan
Holubkov, Richard
Jensen, Hailey
Mifflin, Mark D.
CORNEA, 2024, 43 (08) : 955 - 960
[30] Randomized, controlled, one-year treatment comparison of Timolol-LA (ISTALOL™) given q.d. vs timolol maleate solution given b.i.d. in patients with ocular hypertension or open-angle glaucoma
Novack, GD
Mundorf, TK
Ogawa, T
Crockett, RS
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U375 - U375

← 1 2 3 4 5 →